Achieving Operational Excellence in Pharmaceutical Production
Pharma operational excellence often breaks down after scientific promise is proven. Scale-up exposes weak assumptions. Technology transfer introduces variation. GMP readiness arrives late. Timelines stretch, costs climb, and regulatory confidence erodes. This leads to lost momentum, missed launch windows, deferred revenue, fragile supply plans, and growing pressure from boards, partners, and global health stakeholders to […]